Scandinavian Mirena Insertion Nulliparous Trial.
In this non-interventional study we investigate the nulliparous women individual evaluation of the insertion procedure of LNG-IUD and the follow-up period of 3 months post insertion.
- Nulliparous women Mirena insertion planned as contraceptive method
- Ongoing or suspected pregnancy; - Ongoing or recidivating genital infection; - Cervicitis; - Cervical dysplasia; - Malignancy in uterus or cervix; - Confirmed or suspected hormone sensitive neoplasia including breast cancer - Undiagnosed abnormal uterine bleeding; - Uterine anomaly including myoma if the cavity of the uterus is restricted; - Conditions that cause increased risk of infections; - Acute liver disease or liver tumour; - Allergy to the active substance or any component of the IUD
Many Locations, Sweden
E-mail: [email protected]
Phone: Not Available
Scandinavian Mirena Insertion Nulliparous Trial of an observational study.